[Cardiovascular effects of a new calcium antagonist (RO 11-1781) on atrial fibrillation].
D000368:Aged; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001682:Biological Availability; D001794:Blood Pressure / Q000187:drug effects; D002118:Calcium / Q000037:antagonists & inhibitors*; D004341:Drug Evaluation; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006571:Heterocyclic Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010647:Phenyl Ethers / Q000494:pharmacology / Q000627:therapeutic use
D006571:Heterocyclic Compounds; D010647:Phenyl Ethers; D002118:Calcium
Effetti cardiovascolari di un nuovo farmaco calcio-antagionista (RO 11-1781) nella fibrillazione atriale.